Methylprednisolone Fails to Preserve Retinal Ganglion Cells and Visual Function after Ocular Ischemia in Rats

PURPOSE. Methylprednisolone (MP) is commonly used to treat traumatic optic neuropathy and optic neuritis, but its benefit in terms of neuronal survival remains controversial. The aim of this study was to investigate the effects of MP on retinal ganglion cell (RGC) survival and visual function after ischemia in rats. METHODS. Ocular ischemia was induced by elevated intraocular pressure. Rats were treated with NaCl, 1 mg/kg/d, or 30 mg/kg/d intraperitoneal MP over 3 days. RGCs were labeled retrogradely 4 days after ischemia and were quantified 6 days later. Post-ischemic retinal function was assessed by scotopic and photopic electroretinography (ERG). Optic nerve function was investigated on days 4 and 10 after ischemia by visual evoked potentials (VEPs). RESULTS. Compared with nonischemic eyes, ischemia reduced RGCs with NaCl to 47% +/- 3% (mean +/- SEM) and to 46% +/- 3% and 43% +/- 6% with 1 mg/kg/d and 30 mg/kg/d MP. ERG did not differ significantly for any parameter among the three groups. Four days after ischemia, the VEPs of rats receiving any dose of MP were significantly higher than the control. VEPs in both steroid groups fell to control levels 10 days after ischemia. CONCLUSIONS. Treatment with MP did not improve RGC survival or retinal function. The VEP showed a short-term benefit because of steroids. (Invest Ophthalmol Vis Sci. 2008;49: 5003-5007) DOI:10.1167/iovs.08-1869